<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>APPROVED</status><version>v2</version><patient-age/><report-id>US-PFIZER INC-2013028187</report-id><gender>male</gender><reactions><reaction>ondansetron hydrochloride did not work</reaction><reaction>Vomiting</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>Bosulif</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>ZOFRAN</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Chronic myelogenous leukemia</indication><indication>Philadelphia chromosome positive</indication><indication>Vomiting</indication></indications><outcomes/><country>United States</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>psur</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4254107_P31</messagenumb>
		<messagesenderidentifier>PFIZERINC</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125151547</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>1</safetyreportversion>
		<safetyreportid>US-PFIZER INC-2013028187</safetyreportid>
		<primarysourcecountry>US</primarysourcecountry>
		<occurcountry>US</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2013-01-25</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="2">No</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>2</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>2</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2013-01-21</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2013-01-21</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>2</fulfillexpeditecriteria>
		<companynumb>US-PFIZER INC-2013028187</companynumb>
		<primarysource>
			<reportergivename>Heather</reportergivename>
			<reporterfamilyname>Blanchette</reporterfamilyname>
			<reporterstreet>100 Highland Ave NE</reporterstreet>
			<reportercity>Largo</reportercity>
			<reporterstate>FL</reporterstate>
			<reporterpostcode>33770</reporterpostcode>
			<reportercountry>US</reportercountry>
			<qualification code="3">Other Health Professional</qualification>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>PFIZERINC</senderorganization>
			<senderfamilyname>Head Drug Safety Surveillance</senderfamilyname>
			<senderstreetaddress>150 East 42nd Street</senderstreetaddress>
			<sendercity>New York</sendercity>
			<senderstate>New York</senderstate>
			<senderpostcode>10017</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>2127335544</sendertel>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receivertitle>Mr</receivertitle>
			<receivergivename>Roger</receivergivename>
			<receiverfamilyname>Goetsch</receiverfamilyname>
			<receiverstreetaddress>8201 Corporate Drive, Suite 540</receiverstreetaddress>
			<receivercity>Landover</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20785</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>3019189580</receivertel>
			<receivertelextension>194</receivertelextension>
			<receivertelcountrycode>001</receivertelcountrycode>
			<receiverfax>3019183134</receiverfax>
			<receiverfaxcountrycode>001</receiverfaxcountrycode>
		</receiver>
		<patient>
			<patientinitial>UNKNOWN</patientinitial>
			<patientsex code="1">Male</patientsex>
			<reaction>
				<primarysourcereaction>ondansetron hydrochloride did not work</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Drug ineffective</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Drug ineffective</reactionmeddrapt>
				<reactionstartdateformat>610</reactionstartdateformat>
				<reactionstartdate>201301</reactionstartdate>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Vomiting</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Vomiting</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Vomiting</reactionmeddrapt>
				<reactionstartdateformat>610</reactionstartdateformat>
				<reactionstartdate>201301</reactionstartdate>
				<reactionoutcome code="3">not recovered/not resolved</reactionoutcome>
			</reaction>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>Bosulif</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationnumb>203341</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Pfizer, Inc.</drugauthorizationholder>
				<drugstructuredosagenumb>500</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>500 mg, 1x/day</drugdosagetext>
				<drugdosageform normalized="film-coated tablet">Film-coated tablet</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Chronic myelogenous leukemia</drugindication>
				<drugstartdateformat>610</drugstartdateformat>
				<drugstartdate>2013-01-01</drugstartdate>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>BOSUTINIB</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Drug ineffective</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Drug ineffective</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Vomiting</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Vomiting</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>Bosulif</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationnumb>203341</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Pfizer, Inc.</drugauthorizationholder>
				<drugdosageform normalized="film-coated tablet">Film-coated tablet</drugdosageform>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Philadelphia chromosome positive</drugindication>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>BOSUTINIB</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Drug ineffective</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Drug ineffective</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Vomiting</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Vomiting</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>ZOFRAN</medicinalproduct>
				<drugdosagetext>UNK</drugdosagetext>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Vomiting</drugindication>
				<drugstartdateformat>610</drugstartdateformat>
				<drugstartdate>2013-01-01</drugstartdate>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>ONDANSETRON HYDROCHLORIDE</activesubstancename>
				</activesubstance>
			</drug>
			<summary>
				<narrativeincludeclinical>This is a spontaneous report from the non clinical program Pfizer for Professionals Customer Support from a Pfizer <Semaphore x="2473907" class="Occupation" value="Salesperson" score="1.00" ID="C75553">sales </Semaphore>representative reporting on behalf of a contactable <Semaphore x="2326472" class="Occupation" value="Nurse Practitioner" score="1.00" ID="C20852"><Semaphore x="1642550" class="Procedure" value="Breast Feels Heavy" score="1.00" ID="C105748">nurse </Semaphore>practitioner</Semaphore>. A male patient (age and ethnicity unknown) started to receive <Semaphore x="236393" class="Medicine" value="bosutinib" score="0.93" ID="224558">bosutinib </Semaphore>(<Semaphore x="236312" class="Medicine" value="Bosulif" score="0.49" ID="224564">BOSULIF</Semaphore>) tablet <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">orally</Semaphore>, on an unknown date from Jan2013 at 500mg daily for <Semaphore x="1780469" class="Disease or Finding" value="Chronic Myelogenous Leukemia, BCR-ABL1 Positive" score="1.00" ID="C3174"><Semaphore x="2859866" class="MedDRA LLT" value="Chromosome analysis abnormal" score="1.00" ID="10008817">Philadelphia chromosome positive </Semaphore>(Ph+) <Semaphore x="1779493" class="Disease or Finding" value="Chronic Leukemia" score="1.00" ID="C3483">chronic <Semaphore x="3120003" class="MedDRA LLT" value="Myeloid leukaemia" score="1.00" ID="10028549">myelogenous leukemia </Semaphore></Semaphore></Semaphore>(<Semaphore x="1780469" class="Disease or Finding" value="Chronic Myelogenous Leukemia, BCR-ABL1 Positive" score="1.00" ID="C3174">CML</Semaphore>) and <Semaphore x="950248" class="Medicine" value="Ondansetron Hydrochloride" score="0.93" ID="241452">ondansetron hydrochloride </Semaphore>(<Semaphore x="1384663" class="Medicine" value="Zofran" score="0.74" ID="279237">ZOFRAN</Semaphore>) from an unknown date in Jan2013 at an unknown <Semaphore x="1863371" class="Procedure" value="Dose Frequency" score="1.00" ID="C89081">dose and frequency </Semaphore>for <Semaphore x="2693861" class="Disease or Finding" value="Vomiting" score="1.00" ID="C3442">vomiting</Semaphore>. Medical history and concomitant medications were unknown. The patient started to experience <Semaphore x="2693861" class="Disease or Finding" value="Vomiting" score="1.00" ID="C3442">vomiting </Semaphore>since an unknown date in Jan2013 while being on <Semaphore x="236393" class="Medicine" value="bosutinib" score="0.93" ID="224558">bosutinib</Semaphore>. This was elaborated as the patient experiences <Semaphore x="2693861" class="Disease or Finding" value="Vomiting" score="1.00" ID="C3442">vomiting </Semaphore>every time after 14-16 minutes of taking <Semaphore x="236393" class="Medicine" value="bosutinib" score="0.93" ID="224558">bosutinib</Semaphore>. It was reported that <Semaphore x="950248" class="Medicine" value="Ondansetron Hydrochloride" score="0.93" ID="241452">ondansetron hydrochloride </Semaphore>did not work for the patient since an unknown date in Jan2013; this was elaborated as the medication worked only one time out of four times for <Semaphore x="2693861" class="Disease or Finding" value="Vomiting" score="1.00" ID="C3442">vomiting</Semaphore>. The relevant laboratory data was unknown. The patient was continuing with the <Semaphore x="236393" class="Medicine" value="bosutinib" score="0.93" ID="224558">bosutinib </Semaphore><Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">therapy </Semaphore>while the last action taken with <Semaphore x="950248" class="Medicine" value="Ondansetron Hydrochloride" score="0.93" ID="241452">ondansetron hydrochloride </Semaphore>in <Semaphore x="1854566" class="Disease or Finding" value="Disease Response" score="1.00" ID="C50995">response </Semaphore>to the event was unknown. Therapeutic measure taken for the event <Semaphore x="2693861" class="Disease or Finding" value="Vomiting" score="1.00" ID="C3442">vomiting </Semaphore>included <Semaphore x="950248" class="Medicine" value="Ondansetron Hydrochloride" score="0.93" ID="241452">ondansetron hydrochloride </Semaphore>(<Semaphore x="1384663" class="Medicine" value="Zofran" score="0.74" ID="279237">ZOFRAN</Semaphore>) since an unknown date in Jan2013 (<Semaphore x="1863371" class="Procedure" value="Dose Frequency" score="1.00" ID="C89081">dose and frequency </Semaphore>unknown). The <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>of <Semaphore x="2693861" class="Disease or Finding" value="Vomiting" score="1.00" ID="C3442">vomiting </Semaphore>was not recovered and the <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>of <Semaphore x="950292" class="Medicine" value="Ondansetron" score="0.49" ID="252193">ondansetron </Semaphore>did not work was unknown.</narrativeincludeclinical>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>